| Not Yet Recruiting | Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome NCT07352488 | Henan University of Traditional Chinese Medicine | N/A |
| Recruiting | ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar NCT07425639 | Celltrion HealthCare France | — |
| Recruiting | Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study NCT07055542 | University of Melbourne | N/A |
| Recruiting | Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and W NCT06960382 | University of Zurich | Phase 1 / Phase 2 |
| Enrolling By Invitation | A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies NCT07114133 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Recruiting | Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients NCT07342803 | Longbio Pharma | Phase 2 |
| Terminated | A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in NCT06592768 | Jasper Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | Trial of JYB1904 in Patients With Allergic Asthma NCT06438757 | Jemincare | Phase 2 |
| Completed | A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma NCT06486662 | OM Pharma SA | Phase 1 |
| Active Not Recruiting | Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma NCT06771934 | Qianfoshan Hospital | — |
| Unknown | Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic NCT06151938 | ALK-Abelló A/S | — |
| Not Yet Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen NCT05641272 | Inmunotek S.L. | Phase 2 / Phase 3 |
| Unknown | The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma NCT05749237 | Istanbul University - Cerrahpasa | N/A |
| Completed | A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers NCT06494345 | AO GENERIUM | Phase 1 |
| Unknown | Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivit NCT05400811 | Inmunotek S.L. | Phase 3 |
| Completed | Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract NCT05297760 | University of Zurich | Phase 1 / Phase 2 |
| Unknown | Airway Immune Response to Allergens (Use Lay Language Here) NCT04619017 | JOSALYN CHO | Phase 1 |
| Completed | Andosan in Allergic and Asthma Patients NCT05192720 | University Hospital, Akershus | N/A |
| Recruiting | Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma NCT05008965 | Oneness Biotech Co., Ltd. | Phase 2 |
| Completed | Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure NCT06267261 | Alyatec | N/A |
| Recruiting | A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3) NCT04699604 | Bridgette Jones | Phase 3 |
| Completed | Kinetics of Nasal Cytokine Responses to Mechanical Stimulation NCT04878237 | Medical University of Vienna | N/A |
| Unknown | Environmental Pollutants and Their Effects on Respiratory Allergy NCT04902989 | Cindy Elizabeth de Lira-Quezada | — |
| Completed | Effectiveness and Safety of Omalizumab in Children With Allergic Asthma. NCT05424523 | Novartis Pharmaceuticals | — |
| Completed | Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Ast NCT05813470 | Cinnagen | Phase 3 |
| Completed | Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients NCT04673591 | T-Balance Therapeutics GmbH | Phase 2 |
| Withdrawn | abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies NCT04442932 | Abionic SA | — |
| Completed | Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses NCT04648813 | University of Saskatchewan | Phase 4 |
| Active Not Recruiting | Tyrosine Allergoid Paediatric and Adult Study NCT05186025 | Allergy Therapeutics | — |
| Withdrawn | Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Com NCT04401631 | Abionic SA | — |
| Unknown | Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma NCT04542902 | Lithuanian University of Health Sciences | N/A |
| Completed | Anti-inflammatory Effects Glycopyrronium NCT04259164 | University Medical Center Groningen | Phase 3 |
| Unknown | Gender Differences and SNPs in Asthmatic Patients NCT04567212 | University of Catanzaro | — |
| Completed | Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglob NCT04389034 | Allergy Therapeutics | — |
| Unknown | Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma NCT04264377 | University Medical Center Groningen | — |
| Completed | Documentation of Efficacy of Intralymphatic Allergen Immunotherapy NCT05191186 | Aarhus University Hospital | Phase 3 |
| Unknown | Effect of a Dietary Fatty Acid Supplementation on Symptoms and Bronchial Inflammation in Patients With Asthma NCT04109534 | Stefan Zielen | N/A |
| Unknown | Immune Response Features in Allergic Airway Diseases NCT04352088 | Lithuanian University of Health Sciences | — |
| Completed | Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study NCT03776773 | University Hospital, Grenoble | N/A |
| Unknown | Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest NCT03820154 | Prof. Dr. Claus Bachert BVBA | N/A |
| Completed | Intervention in Chronic Pediatric Patients and Their Families. NCT04476433 | University of Valencia | N/A |
| Completed | Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients NCT03850626 | Leti Pharma GmbH | — |
| Unknown | Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment NCT03431961 | Gail Gauvreau | N/A |
| Completed | Children's Respiratory and Environmental Workgroup NCT03213184 | University of Wisconsin, Madison | — |
| Withdrawn | House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance NCT03307278 | China Medical University Hospital | N/A |
| Unknown | Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma NCT03388359 | Lithuanian University of Health Sciences | N/A |
| Completed | Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma NCT04678063 | Alyatec | N/A |
| Terminated | Pemirolast in Allergen Challenge (PEMAG) NCT03119714 | Karolinska University Hospital | Phase 2 |
| Completed | Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure NCT02911688 | University of North Carolina, Chapel Hill | Phase 2 |
| Completed | Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Mite Allergic Subjects With Asthma NCT04663880 | Alyatec | N/A |
| Completed | AsthMatic Inflammation and Neurocircuitry Activation (MINA) NCT02764437 | University of Wisconsin, Madison | — |
| Suspended | To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Fa NCT02767973 | University of North Carolina, Chapel Hill | N/A |
| Completed | Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific NCT02908360 | Nantes University Hospital | — |
| Completed | Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou NCT02504528 | Guangzhou Institute of Respiratory Disease | N/A |
| Unknown | Specific Immunotherapy for Allergic Child NCT02965612 | Mariella Enoc | N/A |
| Completed | Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations NCT03861910 | Federico II University | — |
| Completed | Efficacy Of Bacterial Lysate In Asthmatic Children NCT02541331 | Lallemand Pharma AG | Phase 3 |
| Completed | Eosinophil Induced Remodelling in Asthma NCT02648074 | Lithuanian University of Health Sciences | N/A |
| Completed | Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma NCT01612715 | Hamilton Health Sciences Corporation | — |
| Completed | Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) NCT02096237 | Fresenius Medical Care Deutschland GmbH | N/A |
| Unknown | The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases NCT02214303 | Lithuanian University of Health Sciences | — |
| Completed | Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract NCT01821716 | Laboratorios Leti, S.L. | Phase 2 |
| Completed | Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression NCT02023151 | Johns Hopkins University | Phase 4 |
| Completed | A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma NCT01703312 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Change in Airway Responsiveness After Allergen Exposure NCT01699594 | University of Saskatchewan | N/A |
| Unknown | The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy NCT01776177 | Joseph D. Diaz, MD | — |
| Completed | A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 NCT01544348 | MedImmune LLC | Phase 1 |
| Completed | Cobra (Severe Asthma)Medical-economic NCT01669681 | University Hospital, Montpellier | — |
| Completed | Characterization of the Role of Histamine in Children With Asthma NCT01392859 | Children's Mercy Hospital Kansas City | Phase 2 / Phase 3 |
| Withdrawn | The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Child NCT01144910 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children NCT01328886 | Novartis Pharmaceuticals | Phase 3 |
| Enrolling By Invitation | Asthma Inflammation Research NCT01536522 | The Cleveland Clinic | EARLY_Phase 1 |
| Completed | Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma NCT01976208 | Shanghai Zhangjiang Biotechnology Limited Company | Phase 2 / Phase 3 |
| Completed | Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy NCT01479205 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) NCT01155700 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy NCT01125748 | Genentech, Inc. | Phase 4 |
| Completed | 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma NCT01353755 | Allergopharma GmbH & Co. KG | Phase 3 |
| Completed | The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen NCT00999466 | AstraZeneca | Phase 2 |
| Completed | Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma NCT00980707 | Associated Scientists to Help Minimize Allergies | Phase 4 |
| Completed | Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent NCT00813748 | Genentech, Inc. | — |
| Completed | A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild All NCT00781443 | Genentech, Inc. | Phase 2 |
| Unknown | Effect of Montelukast on Basophils, In-vitro NCT00710450 | Creighton University | — |
| Completed | Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despit NCT00670930 | Novartis Pharmaceuticals | Phase 4 |
| Terminated | Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen NCT00622362 | Laboratorios Leti, S.L. | Phase 2 |
| Completed | The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinit NCT01318954 | Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. | — |
| Completed | Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma NCT00550797 | Syntara | Phase 2 |
| Completed | Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI NCT00565591 | Respirics Inc. | Phase 1 |
| Completed | A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic As NCT00434434 | Genentech, Inc. | Phase 2 |
| Completed | Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma NCT00485576 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Completed | Safety and Repeatability of Bronchial Challenge With Grass-pollen NCT00507039 | Johann Wolfgang Goethe University Hospital | — |
| Completed | A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma NCT00406965 | Genentech, Inc. | Phase 2 |
| Completed | Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics NCT00581048 | Vanderbilt University | N/A |
| Completed | Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK) NCT00421018 | Karolinska Institutet | N/A |
| Completed | Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma NCT00492076 | ALK-Abelló A/S | Phase 4 |
| Completed | Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctiv NCT00396409 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinoph NCT00283504 | Children's Hospital of The King's Daughters | Phase 4 |
| Completed | Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients NCT00267202 | Novartis | Phase 4 |
| Completed | Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics NCT00535431 | Aerovance, Inc. | Phase 2 |
| Completed | Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Ch NCT00515775 | Technische Universität Dresden | — |
| Completed | Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma NCT00736801 | University of Rostock | N/A |
| Completed | Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite NCT00652223 | Cytos Biotechnology AG | Phase 1 / Phase 2 |
| Completed | A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study) NCT00535028 | Aerovance, Inc. | Phase 2 |
| Completed | A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge NCT01365533 | AstraZeneca | Phase 2 |
| Completed | Fish Oil and Asthma in House Dust Mite Allergy NCT00380926 | Johann Wolfgang Goethe University Hospital | Phase 2 / Phase 3 |
| Unknown | Effect of Xolair on Airway Hyperresponsiveness NCT00208234 | Creighton University | Phase 4 |
| Completed | The Effect of Salmeterol on Eosinophil (EOS) Function NCT00214019 | University of Wisconsin, Madison | N/A |
| Completed | Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma NCT00829179 | Duke University | Phase 3 |
| Completed | Prevention of Asthma and Allergy by Probiotic Lactobacillus GG NCT00490425 | Johann Wolfgang Goethe University Hospital | Phase 4 |
| Withdrawn | Role of Indoor Pollutants on House Dust Mite Allergic Asthma NCT01019291 | University Hospital, Strasbourg, France | N/A |